Epstein-Barr Virus (EBV) is a human tumor virus causally associated with several lyrnphomas and carcinomas. It efficiently induces and maintains proliferation of the B-lymphocytes it naturally infects until the immune response can limit that infection. EBV's proliferative effects on infected cells likely underlie its pathogenicity. One of the few EBV genes contributing these proliferative effects is its latent membrane protein-1 (LMP-1). LMP-1 is found at the plasma membrane where its carboxy terminal domain associates with several cellular signaling molecules which are also bound by TNF and CD40 receptors. LMP-1's signaling domain has been studied extensively in cells in the absence of other viral genes. It has also been studied in recombinant EBV's which for technical reasons have allowed only qualitative findings. We have developed a means to isolate pure recombinant EBV's, termed """"""""maxiEBV's,"""""""" with high titers allowing us to assess quantitatively individual elements of LMP-1 in transformation assays. We hypothesize that multiple activities of LMP-1 contribute to its efficient signaling to support EBV's induction and maintenance of proliferation of infected cells. We shall test this hypothesis genetically with maxi-EBVs in Aim I and by identifying the cellular genes which are the immediate targets of LMP- l's distinct signaling activities in Aim IV. LMP-1 signals in the apparent absence of a ligand with its six membrane spanning domains supporting its aggregation in lieu of that contributed by ligand-binding. It traffics to the plasma membrane and to membrane rafts where it is found as a signaling complex again in the apparent absence of a ligand. We hypothesize that LMP-1 represents a currently undefined solution to the problem of regulating signaling. We shall test this hypothesis by elucidating the path by which LMP-1 transits to the plasma membrane, the moieties it requires for aggregation, and the temporal order and requirements for it to move to membrane rafts and form a signaling complex in Aims II and III. These studies will be confirmed and extended genetically with maxi-EBVs to place them in the context of infection with EBV. All of the proposed research will quantify the contributions of known activities and new activities of LMP-1 that it provides EBV's infected cells.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA070723-07
Application #
6624013
Study Section
Virology Study Section (VR)
Program Officer
Daschner, Phillip J
Project Start
1996-08-15
Project End
2007-03-31
Budget Start
2003-04-01
Budget End
2004-03-31
Support Year
7
Fiscal Year
2003
Total Cost
$283,243
Indirect Cost
Name
University of Wisconsin Madison
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Chiu, Ya-Fang; Sugden, Bill (2018) Plasmid Partitioning by Human Tumor Viruses. J Virol 92:
Albanese, Manuel; Tagawa, Takanobu; Buschle, Alexander et al. (2017) MicroRNAs of Epstein-Barr Virus Control Innate and Adaptive Antiviral Immunity. J Virol 91:
Chiu, Ya-Fang; Sugden, Arthur U; Fox, Kathryn et al. (2017) Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally. J Cell Biol 216:2745-2758
Albanese, Manuel; Tagawa, Takanobu; Bouvet, Mickaël et al. (2016) Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells. Proc Natl Acad Sci U S A 113:E6467-E6475
Tagawa, Takanobu; Albanese, Manuel; Bouvet, Mickaël et al. (2016) Epstein-Barr viral miRNAs inhibit antiviral CD4+ T cell responses targeting IL-12 and peptide processing. J Exp Med 213:2065-80
Chiu, Ya-Fang; Sugden, Bill (2016) Epstein-Barr Virus: The Path from Latent to Productive Infection. Annu Rev Virol 3:359-372
Chakravorty, Adityarup; Sugden, Bill (2015) The AT-hook DNA binding ability of the Epstein Barr virus EBNA1 protein is necessary for the maintenance of viral genomes in latently infected cells. Virology 484:251-8
Hammerschmidt, Wolfgang (2015) The Epigenetic Life Cycle of Epstein-Barr Virus. Curr Top Microbiol Immunol 390:103-17
Steinbrück, Lisa; Gustems, Montse; Medele, Stephanie et al. (2015) K1 and K15 of Kaposi's Sarcoma-Associated Herpesvirus Are Partial Functional Homologues of Latent Membrane Protein 2A of Epstein-Barr Virus. J Virol 89:7248-61
Shrestha, Prabha; Sugden, Bill (2014) Identification of properties of the Kaposi's sarcoma-associated herpesvirus latent origin of replication that are essential for the efficient establishment and maintenance of intact plasmids. J Virol 88:8490-503

Showing the most recent 10 out of 62 publications